The dedicated physicians of the Pediatric/Developmental Ophthalmology Service offer specialized care in conditions that affect infants, toddlers and young adults. Two of the nation’s strongest programs, the USC Roski Eye Institute and the Vision Center at the Children’s hospital of Los Angeles (CHLA) join forces to provide the most advanced expertise in pediatric ophthalmic care. This service is the largest and only program in the country that exclusively provides treatment in almost every ophthalmic subspecialty.
The Vision Center at CHLA is a conglomerate of several institutions including:
- Contact Lens Program
- Cornea Institute
- Eye Birth Defects Institute
- Eye Technology Institute
- Orbit & Eye Movement Institute
- Orthoptics Program
- Retina Institute
- Retinoblastoma Program
- Vision Development Institute
The USC Roski Eye Institute continues to be ranked among the top 10 ophthalmology programs in the country by both U.S. News & World Report and Ophthalmology Times. Children’s Hospital Los Angeles is one of the nation’s top five best children’s hospitals, according to U.S. News and World Report. This partnership allows for cutting edge care backed by years of research and the best ophthalmologists in the field of pediatric care. If your child is experiencing eye disease, injury, and more, get in touch with a member of our team for a consultation, diagnosis, and the treatment he or she needs by filling out the online contact form or calling us today at 323-442-6335.
Conditions We Treat
Pediatric Ophthalmology-examples of some of the major conditions treated
- Corneal Diseases
- Ocular Oncology
- Ocular Trauma
- Neuro-Ophthalmology, Optic Nerve Diseases
- Retinal Disorders
Diagnostic Services and Treatments
Please visit the Vision Center at CHLA website, for further details regarding diagnostic services available for the treatment and management of pediatric ophthalmic conditions. The pediatric ophthalmologists have access to the latest state-of-the-art diagnostic technology such as an innovative technique, developed at CHLA, for early detection of retinal detachment from retinopathy of prematurely (ROP), that combines a tiny endoscope coupled with a portable, bedside spectral domain optical coherence tomograph (SDOCT).
Advances in Pediatric Research
In collaboration with the USC Roski Eye Institute, CHLA’s outstanding clinician-scientists and researchers continue to advance the field of Pediatric Ophthalmology. Some of their landmark achievements are listed below:
- Dr. David Cobrinik, vision scientist, identified the gene that causes retinoblastoma (Rb), eye cancer most prevalent in children under five years of age
- Dr. A. Linn Murphree, was the recipient of the prestigious Stallard Award at the International Society of Ocular Oncology in Paris, France, in 2015, recognizing his research achievements in identifying the genetic mutation causing retinoblastoma.
- Chemoreduction Rb treatment, a combined approach of systemic chemotherapy followed by focal laser or freezing was first pioneered here
- The first in the nation to implant an artificial cornea in a pediatric patient
- Conducting the largest-ever clinical research study in the treatment of optic nerve hyperplasia (ONH)
Timely diagnosis and treatment interventions of pediatric eye conditions can mean a world of difference in the long-term eye health and well-being of a child. Get in touch with the pediatric ophthalmologists at USC today by contacting us online or dialing 323-442-6335 today and receive skilled treatment tailored to your child’s unique needs.
Please visit our Doctors page for summaries of the basic/translational and clinical research being conducted by our clinicians.
Next, read about our Laser Vision Correction Service.